Product Images Duloxetine Delayed-release
View Photos of Packaging, Labels & Appearance
- Chemical Structure - duloxetine 01
- Figure 1 - duloxetine 02
- Figure 2 - duloxetine 03
- Figure 3 - duloxetine 04
- Figure 4 - duloxetine 05
- Figure 5 - duloxetine 06
- Figure 6 - duloxetine 07
- Figure 7 - duloxetine 08
- Figure 8 - duloxetine 09
- Figure 9 - duloxetine 10
- Figure 10 - duloxetine 11
- Label - lbl721621599
Product Label Images
The following 12 images provide visual information about the product associated with Duloxetine Delayed-release NDC 72162-1599 by Bryant Ranch Prepack, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.
Figure 2 - duloxetine 03

Proportion of Patients with Relapse: The provided text includes some numbers and labels related to the proportion of patients with relapse, although it is not clear what these numbers represent. The text also mentions a treatment comparison between a placebo and a medication called "Duloxetine Delayed-Release Capsules". Additionally, there is a time indication in days related to the "Time from Randomization to Relapse". Without more context or a clear explanation, it is difficult to provide a more detailed description or analysis.*
Figure 8 - duloxetine 09

Percentage of Patients Improved: The text provided appears to be incomplete. It mentions Pacabo and DUL 120 mg once daily, but does not provide clear information about the percentage of patients improved or the scale used for measurement. Therefore, the available information is not sufficient to generate a useful description.*
Label - lbl721621599

This appears to be the description of a medication called Duloxetine Hydrochloride in the form of delayed-release capsules. Each capsule contains 67.3 mg of the active ingredient. The National Drug Code (NDC) for this product is 72162-1599-9. It is equivalent to 60 mg of Duloxetine. The medication should be kept out of reach of children and stored at a temperature between 25°C (77°F) with excursions permitted between 15° to 30°C (59° to 86°F). It should be dispensed in a tightly closed container and is only available with a prescription. The manufacturer provides a Medication Guide for patients that can be obtained at the link provided.*
* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.